Sullivan Helps Amgen In $1.2B Micromet Buy
Biotech giant Amgen Inc. will purchase cancer specialist Micromet Inc. for $1.16 billion in cash, the buyer announced Thursday, touting a novel tumor treatment as part of the deal....To view the full article, register now.
Already a subscriber? Click here to view full article